Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$7.36 - $9.87 $2.3 Million - $3.08 Million
-312,068 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$4.67 - $8.95 $1.48 Million - $2.83 Million
-316,168 Reduced 50.33%
312,068 $2.6 Million
Q4 2018

Feb 14, 2019

SELL
$3.87 - $7.11 $366,489 - $673,317
-94,700 Reduced 13.1%
628,236 $2.5 Million
Q3 2018

Nov 14, 2018

SELL
$5.42 - $6.99 $2.83 Million - $3.65 Million
-522,334 Reduced 41.95%
722,936 $4.97 Million
Q2 2018

Aug 06, 2018

SELL
$5.99 - $8.17 $2.16 Million - $2.94 Million
-359,937 Reduced 22.42%
1,245,270 $8.41 Million
Q3 2017

Nov 14, 2017

BUY
$5.28 - $6.88 $8.48 Million - $11 Million
1,605,207
1,605,207 $9.92 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $657M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Sv Health Investors, LLC Portfolio

Follow Sv Health Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sv Health Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sv Health Investors, LLC with notifications on news.